<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Ahead of OTA, Top Trauma Trends for 2019

Posted by Lindsey Wolejko on 9/9/19 10:00 AM

Ahead of the Orthopedic Trauma Association (OTA) meeting, see what SmartTRAK’s Senior Analyst for Trauma & Extremities, Natasha Weeks, has to say about the latest trends in Trauma.

Natasha recently wrote a fascinating and informative article, " Trauma: Top Trends to Watch in 2019 and Beyond", in which she took a look back at 2018 and identified continuing and emerging trauma trends in the market that are likely to shape the landscape in 2019 and beyond. If you would like to download the article and discover SmartTRAK’s predictions for the top trauma market trends to watch, just click the button below.

Download the "Trauma: Top Trends to Watch" Article

Read More

Topics: Orthopedics-Trauma, SmartTRAK Conferences

SmartTRAK's Q418/FY18 Trauma Market Recap

Posted by Natasha Weeks on 5/1/19 1:07 PM

Sequential improvement despite tough comps, supply disruption and pricing pressure

Read More

Topics: Orthopedics-Trauma

SmartTRAK Start-Up Spotlight: OrthoXel

Posted by Tim Jeavons on 2/21/19 1:30 PM

OrthoXel is an orthopaedic trauma device company focused on evolving fracture fixation through evidence-based biomechanical implant design. The Company thoughtfully designed its flagship Apex Tibial and Femoral Nails with a focus on fundamental principles of bone healing, all while keeping the surgeon’s needs in mind. Every OrthoXel product features innovative locking modes not found in any other implant system on the market and all are meticulously designed and engineered to produce the best possible clinical results for every patient.  

Read More

Topics: Orthopedics-Trauma

Q318 Trauma Market Recap: Pricing Pressure Impacts Growth

Posted by Natasha Weeks on 1/8/19 2:31 PM

Tough comps, supply disruption and the ever-present pricing pressure impacts growth

SmartTRAK reports that the WW Trauma Market experienced a downturn in Q3, posting only +1.1% (reported) growth. The US Market was up +2.0% YoY, but is down sequentially compared to last quarter’s +5.0% gains...

Among the many topics covered in SmartTRAK's Q318 Trauma Market Recap are:

Read More

Topics: Orthopedics-Trauma, Q318 Market Recaps

Q218 Trauma Market Recap: Healthy Growth, Slight Slowdown

Posted by Natasha Weeks on 9/5/18 9:19 AM

US market experiences slight softening as the top four trauma players all post sequential declines in Q218

The WW Trauma Market was up in Q218 – the third consecutive quarter of growth in the +4% range. Internationally, positive sales growth in Europe offset a sequential slowdown in Rest of World (ROW). In Europe, revenues were steady, while ROW sales dipped sequentially as the top players reported softer growth due to tough comps as a result of 2017 tender orders...

Among the many topics covered Q218 Trauma Market Recap are:

Read More

Topics: Orthopedics-Trauma

Key Product Trends in the Orthopedic Trauma Market

Posted by Natasha Weeks on 7/3/18 12:59 PM

SmartTRAK's  Trauma & Extremities Fixations Sr. Analyst Natasha Weeks identified several key product trends at the Orthopaedic Trauma Association’s (OTA) 33rd Annual Meeting in Vancouver, BC Oct. 11-14, 2017, as manufacturers looked to differentiate themselves and gain share in the US Trauma market, projected to reach over $2.2B by 2021. 

Read More

Topics: Orthopedics-Trauma, SmartTRAK Conferences

SmartTRAK Publication Alert: Q118 Trauma Market Recap

Posted by Natasha Weeks on 6/12/18 9:28 AM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Trauma Market Recap.

Read More

Topics: Orthopedics-Trauma

SMARTTRAK'S 2017 Trauma Market Recap Financial Results

Posted by Natasha Weeks on 3/19/18 11:03 AM
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its  2017 Trauma Market Recap and  Financial Dashboard.

Despite slightly tougher US comps in Q4, the Trauma Market ended 2017 with steady, mid-single-digit growth primarily driven from the IM Nailing segment. The strength of the IM Nailing segment has been a multi-year story as a result of trauma market leader DePuy Synthes’ TFNA Nail boosting sales each quarter. Other players such as Smith & Nephew and Zimmer Biomet have followed suit touting their own hip and femur nails as growth drivers during the quarter ...

Read More

Topics: Orthopedics-Trauma

SmartTRAK Publication Alert: Q317 Orthopedics Trauma Quarterly Market Recap

Posted by Natasha Weeks on 12/19/17 2:46 PM

Q317 Trauma Market Recap: Emerging Products, Players Boost the Market

New products and players, along with healthy international sales, gave the Trauma Market a boost in Q317.

By Natasha Weeks, Managing Editor/Sr. Analyst Trauma & Extremities

Strong US growth supported by healthy international sales helped propel the WW Trauma Market up in Q317 – the second quarter with growth. Despite more difficult comps, the trauma segment continued to post yet another quarter of steady growth. IM Nailing, the segment powerhouse, led the charge while Plates & Screws followed suit.

Read More

Topics: Orthopedics-Trauma

Trice Medical: Revolutionizing Orthopedic Diagnostics

Posted by Kristina Meyer on 12/17/17 10:01 PM

At the 2017 Orthopedic Summit (OSET) meeting in Las Vegas, Mark Foster, Trice Medical’s Chief Commercialization Officer and VP of Worldwide Sales, spoke with SmartTRAK's Kristina Meyer about the Company’s revolutionary new technology that is improving the way orthopedic injuries are diagnosed. Trice Medical’s newest product, mi-eye 2, is a fully disposable, integrated camera (the size of a 14-gauge needle) with plug-and-play technology that is FDA cleared to provide illumination and visualization during diagnostic and operative arthroscopic and endoscopic procedures. These procedures can be performed in the clinic setting and provide patients with immediate and definitive diagnoses while significantly reducing the overall cost to the healthcare system.

A transcript of SmartTRAK’s interview with Trice Medical is below, as is the video interview, recorded live at the 2017 OSET meeting: (11:27 min.) 

Read More

Topics: Orthopedics-Trauma

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts